Collecting cancer samples to create living models for research
Official title: ORganoid GeneratioN Study for Cancer
Run by Royal Marsden NHS Foundation Trust · NCT05734963 · Data updated 2026-11-12
This study is collecting cancer samples from patients to create lab-grown models that help researchers understand why some cancers respond to treatment better than others.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Royal Marsden NHS Foundation Trust Academic / other |
| Locations | 1 site (London) |
| Status | Recruiting |
| Started | April 4, 2022 |
| Main results expected | April 12, 2031 |
| Study ends | April 12, 2031 |
| Registry record updated | August 9, 2024 |
| Trial ID | NCT05734963 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults aged 18 and older with histologically proven or suspected cancer who are undergoing an interventional procedure.
✕Probably not a fit
Patients who are unable to undergo sample collection or are pregnant may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to collect cancer samples from patients undergoing surgery or biopsy to develop patient-derived organoid models. By growing these cancer cells in the laboratory, researchers hope to gain a better understanding of cancer biology and why some cancers respond to treatment while others do not. The study will utilize advanced techniques such as DNA sequencing and RNA gene expression analysis to analyze the samples. The ultimate goal is to improve treatment options and outcomes for cancer patients.
Why it matters
Potential benefit: If successful, this study could lead to new treatments or improvements in existing therapies for cancer patients.
How similar studies have gone: Other studies have shown promise in developing organoid models for cancer research, indicating that this approach is both viable and potentially impactful.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 18 years or older * Patients with histologically proven or suspected cancer undergoing an interventional procedure, such as surgery or biopsy * Ability to give informed consent for biological sample collection Exclusion Criteria: * Unable to undergo sample collection * Pregnancy
Where it's running
-
The Royal Marsden Hospital
London, United Kingdom Recruiting
Study contacts
- Principal investigator: Ben O'Leary — Royal Marsden Hospital NHS Foundation Trust
- Study coordinator: Ben O'Leary
- Email: ben.oleary@icr.ac.uk
- Phone: 02071535337
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Genetic Risk Profiling in Prostate Cancer: Patient and Provider Perspectives
This study asks patients and their doctors how genetic risk profiling for prostate cancer might fit into routine care and decision-making.
-
Short-course CT online-adaptive radiotherapy for post-operative endometrial cancer
This trial tests whether delivering post-operative radiotherapy in 5 sessions using CT online-adaptive radiotherapy is safe and feasible for endometrial cancer patients.
-
ctDNA-guided precision care for lung, GIST, colorectal, biliary, and ovarian cancers
This trial tests a blood test that looks for tumor DNA in patients with several cancers to help guide personalized treatment decisions.
-
Personalised neoadjuvant therapy planning for adults with high‑risk soft tissue sarcoma
This project tests whether analyzing tumor tissue and clinical data can help guide neoadjuvant chemotherapy decisions for adults with high‑risk soft tissue sarcomas.
-
Digital exercise program with live virtual group sessions for men on hormone therapy during radiotherapy
This program will test whether a digital exercise program with live virtual group sessions helps men with prostate cancer who are starting or receiving hormone therapy with radiotherapy stick to exercise recommendations and improve health and fatigue.
-
Immediate breast reconstruction using 3D imaging and simulation to measure effects of radiotherapy
This project will test whether 3D surface photos and simulated images help women having a mastectomy with immediate reconstruction feel more confident about their likely appearance, help surgeons plan to reduce later correction surgery, and measure how radiotherapy changes breast shape.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.